Chronic Fatigue Syndrome: Diagnosis, Treatment, and Future Direction.
Graves, B Sue, Patel, Mitsu, Newgent, Hailey et al. · Cureus · 2024 · DOI
Quick Summary
ME/CFS is a serious illness that causes extreme tiredness that doesn't improve with rest and often gets worse with activity. People with ME/CFS also struggle with brain fog, pain, sleep problems, and immune system issues. Right now, doctors don't have a simple blood test or scan to diagnose ME/CFS, which makes it hard to identify and treat the condition properly.
Why It Matters
This comprehensive review consolidates fragmented knowledge about ME/CFS diagnosis and management, helping both patients and clinicians understand the current state of evidence. By identifying diagnostic challenges and highlighting the need for biomarkers, it advocates for improved recognition and research directions that could accelerate better care for ME/CFS patients.
Observed Findings
- ME/CFS is characterized by persistent fatigue not relieved by rest, often worsened by physical or mental activity (post-exertional malaise)
- Patients experience multiple overlapping symptoms including cognitive impairment, pain, sleep disturbance, and immune dysfunction
- No definitive biomarkers currently exist for ME/CFS diagnosis
- Symptom overlap with other conditions makes differential diagnosis challenging
- Lack of standardized diagnostic criteria complicates clinical identification and research
Inferred Conclusions
- ME/CFS is a complex multisystem disorder requiring comprehensive diagnostic approaches that go beyond single symptom assessment
- Development of validated biomarkers and standardized diagnostic criteria is critical for advancing patient care and research
- Improved understanding of pathophysiology is necessary to develop effective treatments
- Future research must prioritize biological mechanism investigation and outcome-based clinical trials
Remaining Questions
- What specific biomarkers could reliably identify ME/CFS and distinguish it from similar conditions?
- Which treatment approaches are most effective for different patient subgroups within the ME/CFS population?
- How do the various symptoms and mechanisms of ME/CFS interconnect, and what are the primary drivers of disease pathology?
- What standardized diagnostic criteria should be adopted globally to improve consistency in diagnosis and research?
What This Study Does Not Prove
This literature review does not establish causation for ME/CFS or identify definitive biomarkers—it documents the current absence of them. It cannot validate any single diagnostic test or treatment as universally effective, and it reflects limitations of existing published research rather than providing new experimental evidence.
Topics
Tags
Metadata
- DOI
- 10.7759/cureus.70616
- PMID
- 39483544
- Review status
- Editor reviewed
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 7 April 2026